BioSpace News Archive

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, announced that its Annual Meeting of Stockholders will be held virtually via live webcast on Wednesday, June 16, 2021 at 1:00pm PT.

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has entered into a licensing and distribution agreement with China Grand Pharmaceutical (Grand Pharma).

NLS Pharmaceutics Ltd., a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that Alex Zwyer, Chief Executive Officer and Co-Founder, is scheduled to present a corporate overview at the LD Micro Virtual Invitational Conference being held on June 8 – June 10, 2021.

Apollo Medical Holdings, Inc., a leading physician-centric, technology-powered healthcare company focused on value-based care, announced that the Company has entered into a definitive agreement with Sun Clinical Laboratories, under which ApolloMed will purchase controlling interests in Sun Labs for $4.0 million.

Seagen Inc. announced that management will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 2:10 p.m. Eastern Time.

INT230-6 monotherapy overall showed an estimated 62% survival at one year, Patients receiving a dose of INT230-6 alone ≥50% of their tumor burden demonstrated a one-year survival estimate of 78%, Combined with pembrolizumab the one-year median overall survival estimate was 88%,

Preceptis Medical, Inc., an innovative surgical technology company dedicated to providing less invasive options for pediatric patients, today announced the launch of their next-generation Hummingbird® Tympanostomy Tube System (TTS) for office-based pediatric ear tube procedures.

Hillstream BioPharma, Inc. today announced that an abstract highlighting the progress of HSB-1216 pipeline candidate is being presented as an online publication only at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from June 4-8, 2021.

HAVN Life Sciences Inc., a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce the completion of the previously announced acquisition of clinical stage intellectual property from Bolt Therapeutics.

Fastest Labs, a Drug, Alcohol and DNA Testing franchise, has added a new location in Cookeville, Tennessee to its growing list of facilities across America.